🙌 Great work by Missak Haigentz highlighting the key breakthroughs in #lungcancer research at #ASCO24, which include 3 of the 5 main plenary sessions! He also describes an #immunotherapy-based randomized ph 2 trial via the Big Ten Cancer Research Consortium he led for Rutgers Cancer Institute & RWJBarnabas. Kudos!

Congratulations, Greg Durm IU Simon Comprehensive Cancer Center and co-authors! Big Ten Cancer Research Consortium LUN18-153, A randomized phase II trial of adjuvant pembro vs observation following curative resection for stage I NSCLC with primary tumors between 1-4 cm. #ASCO24

Congratulations to Howard S Hochster MD of Rutgers Cancer Institute, Vaibhav Sahai of U-M Rogel Cancer Center, Dustin Deming Nataliya Uboha Johnathan Ebben MD, PhD of UW Health | Carbone Cancer Center, and @Anita_Turk of IU Simon Comprehensive Cancer Center on their #ASCO2024 poster highlighting BTCRC-GI22-56.

We are grateful to have had the opportunity to meet with many members and leaders at #ASCO2024. Congratulations to those who presented their published research. We’re honored to contribute to the advancement of oncology.

Oana Danciu (University of Illinois Cancer Center) named Big Ten Cancer Research Consortium steering committee chair cancerletter.com/in-brief/20240…

We invite you to watch a new video to learn about the University of Illinois Cancer Center and our commitment to eliminating cancer health inequities and improving cancer outcomes for all. Click to watch: bit.ly/4b86kwU #CancerResearch #CancerTreatment #CancerSurvivor

AYA Cancer in Focus episode 2 is out just in time for your Independence Day holiday playlist! Join Dr. David Dickens & Helaina Hillyard, an AYA cancer survivor, for an insightful and heartfelt conversation about facing cancer as a young adult. player.captivate.fm/episode/acd395…

Join DRDAVE from UI Holden Comprehensive Cancer Center talking with Helaina Hillyard, an AYA cancer survivor. Tune in for an insightful & heartfelt conversation, as Helaina shares her journey & the unique challenges of facing cancer as a young adult. #AYACancer #AYACSM player.captivate.fm/episode/acd395…

👏👏 Super kudos to Masonic Cancer Center, University of Minnesota Dr. Bachanova for leading this #HL clinical trial for the Big Ten Cancer Research Consortium (together w/ UI Holden Comprehensive Cancer Center Dr Farooq & UW Health | Carbone Cancer Center Dr Kenkere). 🎇🎇Amazing translational science. ➡️The Big 10 CRC #lymphoma team is just getting started! bigtencrc.org/clinical-resea…

Episode 3 of Bridging the Gap is out! Join Coral Omene, MD, PhD as she talks with Tina Butts, a breast cancer survivor, about her experiences as a Black female patient in a clinical trial. player.captivate.fm/episode/27d862…

Congratulations to Mark Burkard, MD, PhD, who has been named director of Holden Comprehensive Cancer Center at the University of Iowa, and will begin his new role on October 1, pending approval from the Iowa Board of Regents! Read more: bigtencrc.org/?p=10405&previ…

The Big Ten Cancer Research Consortium has launched new episodes for each of our podcast series: “Bridging the Gap” and “AYA Cancer in Focus.” Read more about the new episodes and find the links to tune in here: bigtencrc.org/big-ten-crc-re…

The Population Science Clinical Trial Working Group received $5,000 to be used for collaborative research regarding rural cancer survivorship. This is a portion of the 2nd donation given by the Jessen Trust, with the 1st donation of $100,000 given in 2022.bigtencrc.org/pswg-5000-rura…

Daniel Isaac, DO, has been appointed to represent MSU College of Human Medicine on the Big Ten Cancer Research Consortium Steering Committee. Read more: bigtencrc.org/isaac-represen…

In this Q&A, Karine Tawagi MD of UI Health and Samantha Armstrong of IU Simon Comprehensive Cancer Center, both active members of the Big Ten CRC and Hoosier Cancer, share how they launched their TwoOncDocs podcast. Read more: cancer.uillinois.edu/two-onc-docs-w…

In this interview, Yousef Zakharia of UI Holden Comprehensive Cancer Center is interviewed about a Big Ten CRC phase 1/2 trial combining durvalumab and guadecitabine in metastatic kidney cancer. Read more here: urotoday.com/video-lectures…

The Big Ten Conference expansion creates an opportunity for growth of the Big Ten CRC. We have invited the new members – UCLA, University of Oregon, USC, and University of Washington – to join the Big Ten CRC. Plans to expand the Big Ten CRC are proceeding. Read more: bigtencrc.org/big-ten-cancer…

Read University of Washington president’s comments on the university’s entry into the @BigTen, including opportunity to participate in the Big Ten CRC:  washington.edu/president/2024…

Dr. Bailey of UW Health | Carbone Cancer Center UW Health, a visionary Big Ten CRC leader and recent chair of the cancer center director’s committee, is retiring after a career spent helping patients & growing research. His story is featured in @Madison_Mag. Read more: channel3000.com/madison-magazi…

BTCRC-LUN17-127 study manuscript, titled, “Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC)” was published in Lung Cancer. Congrats to all co-authors and study teams! bigtencrc.org/btcrc-lun17-12…